Reports
Reports
Sale
The global mHealth market was valued at USD 70.2 billion in 2023, driven by the increasing technological advancement in healthcare across the globe. The market size is anticipated to grow at a CAGR of 18.86% during the forecast period of 2024-2032 to achieve a value of USD 329.1 billion by 2032.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global mHealth Market Overview
3.1 Global mHealth Market Historical Value (2017-2023)
3.2 Global mHealth Market Forecast Value (2024-2032)
4 Global mHealth Market (2017-2032) Landscape
4.1 Global mHealth Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global mHealth Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Mode of Application
4.2.3 Analysis by Stakeholder
5 Global mHealth Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global mHealth Market Segmentation
6.1 Global mHealth Market (2017-2032) by Type
6.1.1 Market Overview
6.1.2 mHealth Apps
6.1.2.1 Healthcare Apps
6.1.2.2 Medication Management Apps
6.1.3 mHealth Devices
6.1.3.1 Blood Glucose Monitors
6.1.3.2 Cardiac Monitors
6.1.3.3 Hemodynamic Monitors
6.1.3.4 Neurological Monitors
6.1.3.5 Respiratory Monitors
6.1.3.6 Body and Temperature Monitors
6.1.3.7 Remote Patient Monitoring Devices
6.1.3.8 Other Devices
6.1.4 mHealth Services
6.1.4.1 Treatment Services
6.1.4.1.1 Independent Aging Solutions
6.1.4.1.2 Chronic Disease Management
6.1.4.2 Diagnostic Services
6.1.4.3 Monitoring Services
6.1.4.3.1 Remote Patient Monitoring Devices
6.1.4.3.2 Medical Call Centers Manned by Healthcare Professionals
6.1.4.3.3 Teleconsultation
6.1.4.3.4 Post Acute Care Services
6.1.4.4 Wellness and Fitness Solutions
6.1.4.5 Other Services
6.2 Global mHealth Market (2017-2032) by Application
6.2.1 Market Overview
6.2.2 Cardiovascular
6.2.3 Diabetes
6.2.4 Respiratory
6.2.5 Neurology
6.2.6 Others
6.3 Global mHealth Market (2017-2032) by Stakeholder
6.3.1 Market Overview
6.3.2 Mobile Operators
6.3.3 Device Vendors
6.3.4 Healthcare Providers
6.3.5 Application and Content Players
6.4 Global mHealth Market (2017-2032) by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America mHealth Market (2017-2032)
7.1 North America mHealth Market (2017-2032) by Mode of Application
7.1.1 Market Overview
7.1.2 Cardiovascular
7.1.3 Diabetes
7.1.4 Respiratory
7.1.5 Neurology
7.1.6 Others
7.2 North America mHealth Market (2017-2032) by Stakeholder
7.2.1 Market Overview
7.2.2 Mobile operators
7.2.3 Device Vendors
7.2.4 Healthcare Providers
7.2.5 Application and Content Players
7.3 North America mHealth Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe mHealth Market (2017-2032)
8.1 Europe mHealth Market (2017-2032) by Application
8.1.1 Market Overview
8.1.2 Cardiovascular
8.1.3 Diabetes
8.1.4 Respiratory
8.1.5 Neurology
8.1.6 Others
8.2 Europe mHealth Market (2017-2032) by Stakeholder
8.2.1 Market Overview
8.2.2 Mobile operators
8.2.3 Device Vendors
8.2.4 Healthcare Providers
8.2.5 Application and Content Players
8.3 Europe mHealth Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific mHealth Market (2017-2032)
9.1 Asia Pacific mHealth Market (2017-2032) by Application
9.1.1 Market Overview
9.1.2 Cardiovascular
9.1.3 Diabetes
9.1.4 Respiratory
9.1.5 Neurology
9.1.6 Others
9.2 Asia Pacific mHealth Market (2017-2032) by Stakeholder
9.2.1 Market Overview
9.2.2 Mobile operators
9.2.3 Device Vendors
9.2.4 Healthcare Providers
9.2.5 Application and Content Players
9.3 Asia Pacific mHealth Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 Australia
9.3.5 ASEAN
9.3.6 Others
10 Latin America mHealth Market (2017-2032)
10.1 Latin America mHealth Market (2017-2032) by Application
10.1.1 Market Overview
10.1.2 Cardiovascular
10.1.3 Diabetes
10.1.4 Respiratory
10.1.5 Neurology
10.1.6 Others
10.2 Latin America mHealth Market (2017-2032) by Stakeholder
10.2.1 Market Overview
10.2.2 Mobile operators
10.2.3 Device Vendors
10.2.4 Healthcare Providers
10.2.5 Application and Content Players
10.3 Latin America mHealth Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa mHealth Market (2017-2032)
11.1 Middle East and Africa mHealth Market (2017-2032) by Application
11.1.1 Market Overview
11.1.2 Cardiovascular
11.1.3 Diabetes
11.1.4 Respiratory
11.1.5 Neurology
11.1.6 Others
11.2 Middle East and Africa mHealth Market (2017-2032) by Stakeholder
11.2.1 Market Overview
11.2.2 Mobile operators
11.2.3 Device Vendors
11.2.4 Healthcare Providers
11.2.5 Application and Content Players
11.3 Middle East and Africa mHealth Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Koninklijke Philips N.V.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Abbott
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Medtronic
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Apple, Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 AirStrip Technologies Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 AliveCor India
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Omron Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 BioTelemetry, a Philips Company
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Athenahealth, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 AgaMatrix
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Withings
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 iHealth Labs, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Cerner Corporation
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 ZTE Corporation
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Cisco Systems, Inc.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 AT&T Intellectual Property
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 Qualcomm Technologies, Inc.
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
List not exhaustive
18 Global mHealth Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
*The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
The market attained a value of about USD 70.2 billion in 2023, driven by the increasing advancement.
The global mHealth market size is anticipated to grow at a CAGR of 18.9% during the forecast period of 2024-2032 and reach a market value of USD 329.1 billion by 2032.
The increasing prevalence of chronic diseases, growing healthcare expenditure, rising geriatric population, technological advancements, product launches, FDA approvals, and government initiatives are among the major factors aiding the market demand.
The increasing number of strategic collaborations between market players to provide the best technology to increase efficiency and convenience for its users in healthcare such as Medtronic plc partnering with Cosmo Intelligent Medical Devices is a major trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
mHealth is available in the market as applications, services, and devices.
mHealth can find wide applications in medical conditions such as cardiovascular, diabetes, respiratory, and neurology, among others.
Stakeholders include mobile operators, device vendors, healthcare providers, and application and content players.
Key players involved in the market are Koninklijke Philips N.V., Abbott, Medtronic, Apple, Inc., AirStrip Technologies Inc., AliveCor India, Omron Corporation, BioTelemetry, a Philips Company, Athenahealth, Inc., AgaMatrix, Withings, iHealth Labs, Inc., Cerner Corporation, ZTE Corporation, Cisco Systems, Inc., Qualcomm Technologies, Inc., and AT&T Intellectual Property.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.